- Home
- HUM vs CBOE Comparison
HUM vs CBOE Comparison
Compare HUM & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUM | CBOE |
|---|---|---|
| Founded | 1961 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 26.8B |
| IPO Year | 2002 | 2010 |
Fundamental Metrics
Financial Performance| Metric | HUM | CBOE |
|---|---|---|
| Price | $304.22 | $329.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 20 | 9 |
| Target Price | $238.65 | ★ $289.44 |
| AVG Volume (30 Days) | ★ 1.5M | 875.7K |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.46% | 0.94% |
| EPS Growth | N/A | ★ 44.52 |
| EPS | ★ 9.83 | 3.66 |
| Revenue | ★ $129,664,000,000.00 | $2,229,100,000.00 |
| Revenue This Year | $26.15 | N/A |
| Revenue Next Year | $6.07 | $3.54 |
| P/E Ratio | ★ $31.44 | $93.87 |
| Revenue Growth | 10.11 | ★ 239.31 |
| 52 Week Low | $163.11 | $218.14 |
| 52 Week High | $315.66 | $371.18 |
Technical Indicators
Market Signals| Indicator | HUM | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 73.85 | 44.59 |
| Support Level | $250.51 | $248.58 |
| Resistance Level | $315.50 | $371.18 |
| Average True Range (ATR) | 10.97 | 10.28 |
| MACD | -1.61 | -4.36 |
| Stochastic Oscillator | 78.51 | 3.29 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.